Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity
- Status
- COMPLETED
- Phase
- PHASE2
Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer
- Status
- TERMINATED
- Phase
- NA
Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer
- Status
- TERMINATED
- Phase
- PHASE2
E7080 in Combination With Carboplatin + Gemcitabine Versus Carboplatin + Gemcitabine Alone as Second Line Therapy in Patients With Platinum-Sensitive Recurrent Ovarian Cancer by CA125
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Autologous OC-DC Vaccine in Ovarian Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Trial of ABT-888 in Combination With Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Oral ENMD-2076 Administered to Patients With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Liposome-Encapsulated Doxorubicin Citrate With or Without Gemcitabine Hydrochloride in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Examining the Role of Transrectal High Intensity Focused Ultrasound (HIFU) in Rectal Pelvic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Collection of Tissue Samples From Patients With Stage III or Stage IV Ovarian Epithelial Cancer
- Status
- COMPLETED
- Phase
- N/A
Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor
- Status
- TERMINATED
- Phase
- N/A
Irinotecan and Bevacizumab for Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Trial of Best Supportive Care and Either Cisplatin or Paclitaxel to Treat Patients With Primary Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer and Inoperable Malignant Bowel Obstruction
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study to Compare the Efficacy and Safety of Olaparib When Given in Combination With Carboplatin and Paclitaxel, Compared With Carboplatin and Paclitaxel in Patients With Advanced Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182
- Status
- UNKNOWN
- Phase
- N/A